Here are five insights:
1. Hospitals and clinics dominate the market among end-users, boosted by the demand for accurate surgeries and expansion of product reach.
2. In the Americas, the United States dominates the market in terms of revenue. The ACA has driven the adoption of neurology endoscopy devices.
3. Western European countries lead the Europe, Middle East and Africa region, due to improved precision in neurosurgery at lower costs. This region is increasingly focused on early diagnosis, detection and treatment via minimally invasive techniques.
4. The Asia-Pacific region will witness the most significant CAGR of 8.9 percent through 2021. An increased awareness of neurological health and improved healthcare infrastructure will boost market growth in this region.
5. Unterhaching, Germany-based Adeor Medical, Center Valley, Pa.-based Aesculap and Tuttlingen, Germany-based Karl Storz lead the space.
More articles on devices:
SpinalCyte hopes CybroCell will usher in era of innovative spine treatment
Bioactive bone graft substitutes for spinal fusion — Key thoughts from Dr. Hyun Bae
SpineGuard® receives FDA clearance to market its DSG™ integration module for making pedicle screws “smart”